Earnings

Vaxart Q3 EPS $(0.07) Down From $(0.04) YoY, Sales $10.620M Down From $72.413M YoY

Nov 5, 2026 · 06:14 PM ET· updated 2h ago

Vaxart (OTC:VXRT) reported quarterly losses of $(0.07) per share. This is a 75 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $10.620 million in sales this

Why It Matters

Vaxart lost more money per share than last year and had way less sales. When a company's sales shrink this much, watch whether they can fix their business.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

VXRT0.40

+0.00 (+0.00%)

MMM189.51

-4.44 (-2.29%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.